Ken Ogasawara
0000-0002-4264-8927
Bristol-Myers Squibb
1 paper found
Refreshing results…
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
Missing publications? Search for publications with a matching author name.